Echo Therapeutics (OTCB : ECTE) $2.00. Announced last week that the Company has completed the product development work for its Prelude SkinPrep System and now has the commercially ready product to be used in final clinical trials.
Echo anticipates that no further changes will be made to the Prelude SkinPrep System and that the current device will be the one used for sale, subject to FDA market clearance of the product. The final Prelude device replaces the prototype device used in earlier clinical trials and will be tested in the near-term in a study using LMX4 lidocaine cream which should form the basis for a 510-k filing with Ferndale Pharma Group for the enhanced delivery of lidocaine. The Company believes that the addressable market for enhanced, fast acting topical lidocaine exceeds $1 billion.
What They Do: Echo is developing the Symphony tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring system for patients with diabetes and for use in hospital critical care units. Echo is also developing its needle-free Prelude SkinPrep System for transdermal drug delivery of a wide range of novel topical reformulations of widely-used, FDA-approved products.
Microsoft Corp. (Nasdaq: MSFT) $30.86 and HP (NYSE: HPQ) $52.47 jointly announced last week a three-year agreement to invest $250 million to significantly simplify technology environments for businesses of all sizes. With this strategic partnership, HP and Microsoft will collaborate on an engineering road map for data management machines; converged, pre-packaged application solutions; comprehensive virtualization offerings; and integrated management tools. Delivered through the industry’s most extensive sales and partner network.
Under the terms of the expanded partnership, the two companies will increase their global investment by 10 times to drive new opportunities for the 32,000 HP and Microsoft Frontline channel partners.
What They Do: Founded in 1975, Microsoft (Nasdaq “MSFT”) is the worldwide leader in software, services and solutions that help people and businesses realize their full potential. HP, the world’s largest technology company, simplifies the technology experience for consumers and businesses with a portfolio that spans printing, personal computing, software, services and IT infrastructure.
Avago Technologies Limited (Nasdaq: AVGO) $18.24. Announced Friday after market close that, based on preliminary quarter-to-date results, it now expects revenue in the first fiscal quarter ending January 31, 2010 to be up 3.0 - 5.0% sequentially from the fourth fiscal quarter of 2009. Previous guidance issued on December 3, 2009 had been for revenue to be in the range of flat to down 3% sequentially.
What They Do: Avago Technologies is a leading designer, developer and global supplier of a broad range of analog semiconductor devices with a focus on III-V based products.
About SmallCapReview
Copyright SmallCapReview. SmallCapReview.com is a leading site for news on small-caps, penny stocks and microcaps. SmallCapReview has been compensated three thousand five hundred dollars by a third party Green Horseshoe for its services with regards to Echo Therapeutics. SmallCapReview has built a loyal opt-in following for their investor products by providing a newsletter at no cost, sent to subscribers, highlighting select stocks in play, to register visit http://www.smallcapreview.com/. To follow us on Twitter visit http://twitter.com/SmallCapReview.
